Merck says its antiviral pill is less effective in a final analysis.


By BY REBECCA ROBBINS from NYT Science
https://ift.tt/3cRWljD
The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.
Share:

Related Posts:

No comments:

Post a Comment

Popular Posts

Blog Archive

Powered by Blogger.